Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis
UpdatedJul 10, 2026
DataAggregated Company Financials
Companies13
- 7D1.8%
- 3M-18.5%
- 1Y-19.5%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 1.8%, driven by gains from Shin Nippon Biomedical Laboratories of 9.0%. However, the industry is down 19% over the past year. Looking forward, earnings are forecast to grow by 5.1% annually.
Industry Valuation and Performance
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 11 Jul 2026 | JP¥111.2b | JP¥62.8b | JP¥631.5m | 23.6x | 176.1x | 1.8x |
| Mon, 08 Jun 2026 | JP¥109.2b | JP¥62.9b | JP¥618.3m | 24.8x | 176.7x | 1.7x |
| Wed, 06 May 2026 | JP¥137.3b | JP¥63.3b | -JP¥864,496,000.00 | 22.1x | -158.9x | 2.2x |
| Fri, 03 Apr 2026 | JP¥137.6b | JP¥63.3b | -JP¥864,966,000.00 | 20.7x | -159.1x | 2.2x |
| Sun, 01 Mar 2026 | JP¥157.7b | JP¥63.2b | -JP¥944,048,000.00 | 24.7x | -167.1x | 2.5x |
| Tue, 27 Jan 2026 | JP¥150.3b | JP¥66.9b | JP¥72.2m | 23.6x | 2081.4x | 2.2x |
| Thu, 25 Dec 2025 | JP¥150.4b | JP¥66.9b | JP¥72.2m | 21.1x | 2083.3x | 2.2x |
| Sat, 22 Nov 2025 | JP¥149.1b | JP¥67.3b | JP¥574.9m | 18x | 259.4x | 2.2x |
| Mon, 20 Oct 2025 | JP¥138.3b | JP¥66.5b | JP¥1.5b | 16.2x | 94.8x | 2.1x |
| Wed, 17 Sep 2025 | JP¥147.9b | JP¥66.5b | JP¥1.5b | 16.6x | 101.4x | 2.2x |
| Fri, 15 Aug 2025 | JP¥145.1b | JP¥66.6b | JP¥1.2b | 17.2x | 123.3x | 2.2x |
| Sun, 13 Jul 2025 | JP¥142.7b | JP¥66.0b | JP¥1.1b | 16.3x | 126.4x | 2.2x |
| Tue, 10 Jun 2025 | JP¥135.8b | JP¥66.0b | JP¥1.1b | 17.1x | 119.8x | 2.1x |
| Thu, 08 May 2025 | JP¥141.9b | JP¥64.2b | JP¥1.5b | 14.6x | 92.4x | 2.2x |
| Sat, 05 Apr 2025 | JP¥139.6b | JP¥64.8b | JP¥928.0m | 13.3x | 150.4x | 2.2x |
| Mon, 03 Mar 2025 | JP¥161.6b | JP¥65.1b | JP¥1.1b | 15.5x | 144.9x | 2.5x |
| Wed, 29 Jan 2025 | JP¥167.1b | JP¥62.0b | JP¥440.7m | 18.2x | 379.2x | 2.7x |
| Fri, 27 Dec 2024 | JP¥161.3b | JP¥62.0b | JP¥440.7m | 18x | 365.9x | 2.6x |
| Sun, 24 Nov 2024 | JP¥161.9b | JP¥62.6b | JP¥1.2b | 20.2x | 130.6x | 2.6x |
| Tue, 22 Oct 2024 | JP¥155.3b | JP¥61.5b | JP¥1.8b | 22.5x | 84.4x | 2.5x |
| Thu, 19 Sep 2024 | JP¥151.8b | JP¥53.8b | JP¥1.5b | 16.8x | 101.3x | 2.8x |
| Sat, 17 Aug 2024 | JP¥155.9b | JP¥61.8b | JP¥2.1b | 19.2x | 74.4x | 2.5x |
| Mon, 15 Jul 2024 | JP¥164.4b | JP¥61.8b | JP¥3.2b | 26.1x | 50.8x | 2.7x |
| Wed, 12 Jun 2024 | JP¥162.9b | JP¥61.8b | JP¥3.3b | 25.4x | 49.8x | 2.6x |
| Fri, 10 May 2024 | JP¥173.5b | JP¥62.0b | JP¥3.3b | 14.2x | 52.3x | 2.8x |
| Sun, 07 Apr 2024 | JP¥181.2b | JP¥62.3b | JP¥3.3b | 14.5x | 55.1x | 2.9x |
| Tue, 05 Mar 2024 | JP¥240.2b | JP¥155.3b | JP¥8.7b | 14x | 27.6x | 1.5x |
| Thu, 01 Feb 2024 | JP¥224.9b | JP¥167.1b | JP¥8.5b | 15.2x | 26.5x | 1.3x |
| Sat, 30 Dec 2023 | JP¥224.9b | JP¥167.1b | JP¥8.5b | 15x | 26.5x | 1.3x |
| Mon, 27 Nov 2023 | JP¥238.2b | JP¥167.4b | JP¥8.7b | 15.1x | 27.4x | 1.4x |
| Wed, 25 Oct 2023 | JP¥226.6b | JP¥179.3b | JP¥12.8b | 14.1x | 17.7x | 1.3x |
| Fri, 22 Sep 2023 | JP¥249.4b | JP¥179.3b | JP¥12.8b | 15.2x | 19.5x | 1.4x |
| Sun, 20 Aug 2023 | JP¥257.7b | JP¥179.3b | JP¥12.8b | 15.5x | 20.1x | 1.4x |
| Tue, 18 Jul 2023 | JP¥270.1b | JP¥178.5b | JP¥16.2b | 16.6x | 16.6x | 1.5x |
Price to Earnings Ratio
16.6x
Current Industry PE
- Investors are relatively neutral on the Japanese Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 177x.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have declined 66% per year over the last three years,
- Revenues have also declined 29% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Comparison
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | 0.19% | |
| Healthcare | -0.16% | |
| Life Sciences | 1.81% | |
| Clinical Research and Equipment | 1.81% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥1.28k | 9.0% +JP¥4.4b | -8.1% | PE11.6x | |
| 4572 Carna Biosciences | JP¥362.00 | 7.4% +JP¥515.0m | 4.0% | PS12x | |
| 4880 CellSource | JP¥347.00 | 6.8% +JP¥436.6m | -52.9% | PE98.4x | |
| 7707 Precision System Science | JP¥205.00 | 5.1% +JP¥274.6m | 5.1% | PE42x | |
| 130A Veritas In Silico | JP¥437.00 | 1.4% +JP¥38.9m | -34.0% | PS31.1x |